NO20011656L - Medikamentavleveringssystemer med mukosaopprinnelse og dyreanvendelser - Google Patents
Medikamentavleveringssystemer med mukosaopprinnelse og dyreanvendelserInfo
- Publication number
- NO20011656L NO20011656L NO20011656A NO20011656A NO20011656L NO 20011656 L NO20011656 L NO 20011656L NO 20011656 A NO20011656 A NO 20011656A NO 20011656 A NO20011656 A NO 20011656A NO 20011656 L NO20011656 L NO 20011656L
- Authority
- NO
- Norway
- Prior art keywords
- drug delivery
- delivery systems
- animal applications
- mucosal
- mucosa
- Prior art date
Links
- 238000012377 drug delivery Methods 0.000 title abstract 4
- 241001465754 Metazoa Species 0.000 title abstract 2
- 210000004877 mucosa Anatomy 0.000 title 1
- 239000012528 membrane Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Ophthalmology & Optometry (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10295698P | 1998-10-02 | 1998-10-02 | |
| PCT/US1999/022967 WO2000019987A1 (en) | 1998-10-02 | 1999-10-01 | Mucosal originated drug delivery systems and animal applications |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20011656D0 NO20011656D0 (no) | 2001-04-02 |
| NO20011656L true NO20011656L (no) | 2001-04-02 |
Family
ID=22292601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20011656A NO20011656L (no) | 1998-10-02 | 2001-04-02 | Medikamentavleveringssystemer med mukosaopprinnelse og dyreanvendelser |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1117390B1 (no) |
| JP (1) | JP2002526403A (no) |
| KR (1) | KR20010075528A (no) |
| CN (1) | CN1321086A (no) |
| AT (1) | ATE273698T1 (no) |
| AU (1) | AU768040B2 (no) |
| BR (1) | BR9915020A (no) |
| CA (1) | CA2345808A1 (no) |
| CZ (1) | CZ20011188A3 (no) |
| DE (1) | DE69919554T2 (no) |
| ES (1) | ES2228125T3 (no) |
| HU (1) | HUP0103543A2 (no) |
| IL (1) | IL142168A0 (no) |
| MX (1) | MXPA01003310A (no) |
| NO (1) | NO20011656L (no) |
| NZ (1) | NZ510771A (no) |
| PL (1) | PL347061A1 (no) |
| PT (1) | PT1117390E (no) |
| WO (1) | WO2000019987A1 (no) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6331539B1 (en) | 1999-06-10 | 2001-12-18 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
| DE10107659B4 (de) * | 2001-02-19 | 2008-03-13 | Lts Lohmann Therapie-Systeme Ag | Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin |
| CN1897948A (zh) | 2003-10-03 | 2007-01-17 | 3M创新有限公司 | 烷氧基取代的咪唑并喹啉 |
| RU2409576C2 (ru) | 2003-11-25 | 2011-01-20 | 3М Инновейтив Пропертиз Компани | Системы, содержащие имидазольное кольцо с заместителями, и способы их получения |
| FI20041425A0 (fi) | 2004-11-05 | 2004-11-05 | Orion Corp | Transmukosaalinen veterinäärinen koostumus |
| WO2006084251A2 (en) | 2005-02-04 | 2006-08-10 | Coley Pharmaceutical Group, Inc. | Aqueous gel formulations containing immune reponse modifiers |
| JP2006335640A (ja) * | 2005-05-06 | 2006-12-14 | Daicho Kikaku:Kk | 動物用薬剤 |
| KR101464003B1 (ko) * | 2005-07-29 | 2014-11-20 | 산텐 세이야꾸 가부시키가이샤 | 고형 조성물을 이용한 후안부 조직으로의 비침습성 약물전달 시스템 |
| JP2009528900A (ja) * | 2006-03-07 | 2009-08-13 | オラヘルス コーポレーション | 不透過性中央部を有した医療用多層パッチ |
| WO2008011194A2 (en) | 2006-07-21 | 2008-01-24 | Biodelivery Sciences International, Inc. | Transmucosal delivery devices with enhanced uptake |
| DE102008011800A1 (de) | 2008-02-29 | 2009-10-15 | Acino Ag | Oral zerfallender Film zur therapeutischen Anwendung von Antiparasitika bei Tieren |
| AU2010248776B2 (en) * | 2009-05-15 | 2013-06-06 | Baudax Bio, Inc. | Sublingual dexmedetomidine compositions and methods of use thereof |
| JP2012533557A (ja) * | 2009-07-17 | 2012-12-27 | ザ・ボード・オブ・リージェンツ・フォー・オクラホマ・ステート・ユニバーシティ | 舌上ワクチン及びアプリケーター |
| EP2570217B1 (de) | 2011-09-15 | 2014-11-05 | Klingelnberg AG | Semi-Completing Wälzschälverfahren und Vorrichtung mit entsprechendem Wälzschälwerkzeug zum Ausführen eines Semi-Completing Wälzschälverfahrens |
| US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
| JP6188934B2 (ja) * | 2013-10-07 | 2017-08-30 | テイコク ファーマ ユーエスエー インコーポレーテッド | デクスメデトミジン経皮組成物を含む疼痛管理用方法及び組成物 |
| TWI709417B (zh) | 2013-10-07 | 2020-11-11 | 美商帝國製藥美國股份有限公司 | 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物 |
| TWI624278B (zh) * | 2013-10-07 | 2018-05-21 | 帝國製藥美國股份有限公司 | 使用非鎮靜性右美托咪啶經皮組成物用於治療戒斷症候群的方法及組成物 |
| TWI629067B (zh) | 2013-10-07 | 2018-07-11 | 美商帝國製藥美國股份有限公司 | 用於經皮輸送非鎮靜量右美托咪啶之方法及組成物 |
| TWI645866B (zh) | 2013-10-07 | 2019-01-01 | 美商帝國製藥美國股份有限公司 | 右美托咪啶經皮輸送裝置及使用其之方法 |
| EP4251205A1 (en) * | 2020-11-25 | 2023-10-04 | Intervet International B.V. | Method of treatment of pain through buccal administration of flunixin |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB981372A (en) * | 1960-05-04 | 1965-01-27 | Pfizer Ltd | Pharmaceutical formulations for oral administration to animals |
| GB1455251A (en) * | 1972-08-25 | 1976-11-10 | Evode Ltd | Method of sealing gaps and compositions therefor heat |
| US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| US5346701A (en) * | 1993-02-22 | 1994-09-13 | Theratech, Inc. | Transmucosal delivery of macromolecular drugs |
| FR2712807B1 (fr) * | 1993-11-24 | 1996-02-23 | Vetoquinol Sa | Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale . |
| US5688520A (en) * | 1995-03-29 | 1997-11-18 | Minnesota Mining And Manufacturing Company | Transmucosal delivery of melatonin for prevention of migraine |
-
1999
- 1999-10-01 NZ NZ510771A patent/NZ510771A/en unknown
- 1999-10-01 IL IL14216899A patent/IL142168A0/xx unknown
- 1999-10-01 ES ES99954718T patent/ES2228125T3/es not_active Expired - Lifetime
- 1999-10-01 AT AT99954718T patent/ATE273698T1/de not_active IP Right Cessation
- 1999-10-01 PT PT99954718T patent/PT1117390E/pt unknown
- 1999-10-01 BR BR9915020-4A patent/BR9915020A/pt not_active Application Discontinuation
- 1999-10-01 AU AU11001/00A patent/AU768040B2/en not_active Ceased
- 1999-10-01 EP EP99954718A patent/EP1117390B1/en not_active Expired - Lifetime
- 1999-10-01 WO PCT/US1999/022967 patent/WO2000019987A1/en not_active Ceased
- 1999-10-01 PL PL99347061A patent/PL347061A1/xx unknown
- 1999-10-01 CA CA002345808A patent/CA2345808A1/en not_active Abandoned
- 1999-10-01 CZ CZ20011188A patent/CZ20011188A3/cs unknown
- 1999-10-01 JP JP2000573348A patent/JP2002526403A/ja active Pending
- 1999-10-01 HU HU0103543A patent/HUP0103543A2/hu unknown
- 1999-10-01 DE DE69919554T patent/DE69919554T2/de not_active Expired - Fee Related
- 1999-10-01 CN CN99811638A patent/CN1321086A/zh active Pending
- 1999-10-01 KR KR1020017004162A patent/KR20010075528A/ko not_active Withdrawn
- 1999-10-01 MX MXPA01003310A patent/MXPA01003310A/es unknown
-
2001
- 2001-04-02 NO NO20011656A patent/NO20011656L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69919554T2 (de) | 2005-09-01 |
| WO2000019987A1 (en) | 2000-04-13 |
| AU1100100A (en) | 2000-04-26 |
| EP1117390B1 (en) | 2004-08-18 |
| NZ510771A (en) | 2003-08-29 |
| NO20011656D0 (no) | 2001-04-02 |
| JP2002526403A (ja) | 2002-08-20 |
| ATE273698T1 (de) | 2004-09-15 |
| PL347061A1 (en) | 2002-03-11 |
| DE69919554D1 (de) | 2004-09-23 |
| ES2228125T3 (es) | 2005-04-01 |
| KR20010075528A (ko) | 2001-08-09 |
| HUP0103543A2 (hu) | 2002-01-28 |
| IL142168A0 (en) | 2002-03-10 |
| CA2345808A1 (en) | 2000-04-13 |
| EP1117390A1 (en) | 2001-07-25 |
| AU768040B2 (en) | 2003-11-27 |
| CN1321086A (zh) | 2001-11-07 |
| PT1117390E (pt) | 2005-01-31 |
| CZ20011188A3 (cs) | 2001-08-15 |
| MXPA01003310A (es) | 2003-05-15 |
| BR9915020A (pt) | 2001-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20011656D0 (no) | Medikamentavleveringssystemer med mukosaopprinnelse og dyreanvendelser | |
| DK1212422T3 (da) | Humane CTLA-4-antistoffer og anvendelserne deraf | |
| BRPI0411924A (pt) | métodos e dispositivos para oclusão de lúmens de corpo e/ou para fornecimento de agentes terapêuticos | |
| DE60041761D1 (de) | Tribonektine | |
| SV1995000007A (es) | Derivados del acido micofenolico 5-substituidos. | |
| NO20061489L (no) | Formuleringer og fremgangsmater for a behandle inflamatorisk tarmsykdom | |
| ATE531419T1 (de) | Vorrichtung zur verabreichung von therapeutischen mitteln | |
| NO974321D0 (no) | Nodulisporsyrederivater | |
| DK1242012T3 (da) | Forbedret transdermalt præventionsmiddelafgivelsessystem og fremgangsmåde | |
| CY1109221T1 (el) | Χιμαιρικο γονιδιο που κωδικοποιει τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum | |
| ATE337712T1 (de) | Zusammensetzung zur intestinalen verabreichung | |
| DK1082131T3 (da) | Immunoregulator | |
| IS5956A (is) | Notkun bisfosónsýra til varnar og meðhöndlunar sýkingaferla | |
| DK1237562T3 (da) | Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme | |
| CA2285477A1 (en) | Formulations and methods to treat and prevent equine protozoal myeloencephalitis | |
| ATE261724T1 (de) | Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen | |
| BG101145A (bg) | Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа | |
| DE69720016D1 (de) | Nodulisporinsäurederivate | |
| DE60035504D1 (de) | Verfahren für die verabreichung von heilmitteln mittels einer dextrinlösung | |
| UA31156A (uk) | Спосіб лікування пневмоентеритів телят | |
| FR2801300B1 (fr) | Traitement au dioxyde de carbone des eaux de refroidissement atmospherique | |
| DK1196182T3 (da) | Fremgangsmåde til forbedring af produktionsresultat hos dyr | |
| UA32160A (uk) | Спосіб лікування папіломатозу у коней | |
| WO2003028537A3 (en) | Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer | |
| UA38006A (uk) | Хондропротективний препарат |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |